Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Halabi

Showing results (51-60 of 282) with videos related to

Pageof 29
Sort By:
Statistics in Medicine|April 16, 2014
Adjusting for misclassification in a stratified biomarker clinical trialChunling Liu, Aiyi Liu, Jiang Hu, et al.
The American Journal of Clinical Nutrition|July 10, 2020
Best (but oft-forgotten) practices: sample size and power calculation for a dietary intervention trial with episodically consumed foodsWei Zhang, Aiyi Liu, Zhiwei Zhang, et al.
Cancer|August 1, 2007
Inverse correlation between body mass index and clinical outcomes in men with advanced castration-recurrent prostate cancerSusan Halabi, San-San Ou, Nicholas J Vogelzang, et al.
The Journal of Urology|January 16, 2007
The impact of prior radical prostatectomy in men with metastatic castration recurrent prostate cancer: a pooled analysis of 9 Cancer and Leukemia Group B TrialsSusan Halabi, Nicholas J Vogelzang, San-San Ou, et al.
Cancer|December 19, 2013
Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic renal cell carcinomaSusan Halabi, Brian Rini, Bernard Escudier, et al.
Obstetrics and Gynecology|April 2, 2005
Antidepressant medication use [corrected] and risk of ovarian cancerPatricia G Moorman, Andrew Berchuck, Brian Calingaert, et al.
Clinical Trials (London, England)|August 21, 2025
Incorporating data from multiple ongoing trials for Bayesian two-stage phase II single-arm studiesSusan Halabi, Taehwa Choi, Elizabeth Garrett-Mayer, et al.
American Journal of Obstetrics and Gynecology|July 16, 2005
Menopausal hormones and risk of ovarian cancerPatricia G Moorman, Joellen M Schildkraut, Brian Calingaert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2010
Bevacizumab and everolimus in renal cancer: a rational way forwardWalter M Stadler, George Phillips, Daniel J George, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Cancer and Leukemia Group B 90206: A randomized phase III trial of interferon-alpha or interferon-alpha plus anti-vascular endothelial growth factor antibody (bevacizumab) in metastatic renal cell carcinomaBrian I Rini, Susan Halabi, John Taylor, et al.
Pageof 29

Showing results (51-60 of 282) with videos related to

Sort By:
Pageof 29
Statistics in Medicine|April 16, 2014
Adjusting for misclassification in a stratified biomarker clinical trialChunling Liu, Aiyi Liu, Jiang Hu, et al.
The American Journal of Clinical Nutrition|July 10, 2020
Best (but oft-forgotten) practices: sample size and power calculation for a dietary intervention trial with episodically consumed foodsWei Zhang, Aiyi Liu, Zhiwei Zhang, et al.
Cancer|August 1, 2007
Inverse correlation between body mass index and clinical outcomes in men with advanced castration-recurrent prostate cancerSusan Halabi, San-San Ou, Nicholas J Vogelzang, et al.
The Journal of Urology|January 16, 2007
The impact of prior radical prostatectomy in men with metastatic castration recurrent prostate cancer: a pooled analysis of 9 Cancer and Leukemia Group B TrialsSusan Halabi, Nicholas J Vogelzang, San-San Ou, et al.
Cancer|December 19, 2013
Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic renal cell carcinomaSusan Halabi, Brian Rini, Bernard Escudier, et al.
Obstetrics and Gynecology|April 2, 2005
Antidepressant medication use [corrected] and risk of ovarian cancerPatricia G Moorman, Andrew Berchuck, Brian Calingaert, et al.
Clinical Trials (London, England)|August 21, 2025
Incorporating data from multiple ongoing trials for Bayesian two-stage phase II single-arm studiesSusan Halabi, Taehwa Choi, Elizabeth Garrett-Mayer, et al.
American Journal of Obstetrics and Gynecology|July 16, 2005
Menopausal hormones and risk of ovarian cancerPatricia G Moorman, Joellen M Schildkraut, Brian Calingaert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2010
Bevacizumab and everolimus in renal cancer: a rational way forwardWalter M Stadler, George Phillips, Daniel J George, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Cancer and Leukemia Group B 90206: A randomized phase III trial of interferon-alpha or interferon-alpha plus anti-vascular endothelial growth factor antibody (bevacizumab) in metastatic renal cell carcinomaBrian I Rini, Susan Halabi, John Taylor, et al.
Pageof 29